Bliss GVS Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

10.42

10.37

10.31

10.31

10.31

Share application money

-

9.94

9.84

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

926.58

831.12

735.50

672.63

592.96

Loan funds

Secured loans

77.08

85.61

67.87

71.49

66.17

Unsecured loans

-

-

-

-

1.00

Total

1,014.08

937.04

823.52

754.43

670.44

Uses of funds

Fixed assets

Gross block

384.36

269.03

210.61

202.18

93.46

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

58.86

44.02

35.82

22.63

14.45

Net block

325.50

225.00

174.78

179.55

79.01

Capital work-in-progress

2.80

22.15

2.39

-

42.91

Investments

18.26

18.26

18.30

18.31

18.31

Net current assets

Current assets, loans & advances

793.13

814.55

750.14

657.23

595.62

Less : current liabilities & provisions

125.61

142.92

122.10

100.67

65.41

Total net current assets

667.52

671.63

628.04

556.57

530.21

Miscellaneous expenses not written

-

-

-

-

-

Total

1,014.08

937.04

823.52

754.43

670.44

Notes:

Book value of unquoted investments

18.26

18.26

18.30

18.31

18.31

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

10.09

21.81

30.06

14.33

12.18

Number of equity sharesoutstanding (Lacs)

1041.53

1036.78

1031.47

1031.47

1031.47